Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS)
- PMID: 1600854
- DOI: 10.1016/0168-8227(92)90087-8
Risk factors for progression of microvascular complications in the Stockholm Diabetes Intervention Study (SDIS)
Abstract
Ninety-six patients with insulin-dependent diabetes mellitus (IDDM), non-proliferative retinopathy, normal s-creatinine and previously high blood glucose levels were followed for 5 years. In multivariate analyses the mean HbA1c level (14 values during 6-60 months) was significantly correlated with albumin excretion level (P less than 0.01), retinopathy (P less than 0.001), motoric and sensoric nerve conduction velocities (P less than 0.01), thermal threshold on the foot (P less than 0.01), the respiratory sinus arrhythmia (P less than 0.01), the valsalva ratio (P less than 0.05) and the orthostatic blood pressure reaction (P = 0.05) after 5 years. Neuropathy was related to both the HbA1c value at baseline (P less than 0.05) and the mean HbA1c value during the study (P less than 0.001). Smoking habits were correlated with the total number of complications deteriorating (P less than 0.05), as was HbA1c during the study (P less than 0.001). Patients with an initial HbA1c of 9% or more could reduce the risks for deterioration of microvascular complications to 10-15% by reducing their HbA1c below this level.
Similar articles
-
The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.Diabetes. 1996 Oct;45(10):1289-98. Diabetes. 1996. PMID: 8826962 Clinical Trial.
-
The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.Diabetes. 1995 Aug;44(8):968-83. Diabetes. 1995. PMID: 7622004 Clinical Trial.
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.Diabetes Res Clin Pract. 1995 May;28(2):103-17. doi: 10.1016/0168-8227(95)01064-k. Diabetes Res Clin Pract. 1995. PMID: 7587918 Clinical Trial.
-
Blood glucose control and microvascular complications--what do we do now?Diabetologia. 1994 Dec;37(12):1172-7. doi: 10.1007/BF00399789. Diabetologia. 1994. PMID: 7895945 Review. No abstract available.
-
Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia.Diabet Med. 1992 Oct;9(8):697-705. doi: 10.1111/j.1464-5491.1992.tb01876.x. Diabet Med. 1992. PMID: 1395460 Review. No abstract available.
Cited by
-
Glucose targets for preventing diabetic kidney disease and its progression.Cochrane Database Syst Rev. 2017 Jun 8;6(6):CD010137. doi: 10.1002/14651858.CD010137.pub2. Cochrane Database Syst Rev. 2017. PMID: 28594069 Free PMC article.
-
A risk-benefit assessment of conventional versus intensive insulin therapy.Drug Saf. 1994 Mar;10(3):196-202. doi: 10.2165/00002018-199410030-00002. Drug Saf. 1994. PMID: 8043222 Review.
-
Vasodilatory effects of glucagon: A possible new approach to enhanced subcutaneous insulin absorption in artificial pancreas devices.Front Bioeng Biotechnol. 2022 Sep 21;10:986858. doi: 10.3389/fbioe.2022.986858. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36213069 Free PMC article.
-
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease.Cochrane Database Syst Rev. 2018 Sep 24;9(9):CD011798. doi: 10.1002/14651858.CD011798.pub2. Cochrane Database Syst Rev. 2018. PMID: 30246878 Free PMC article.
-
The α7-nicotinic acetylcholine receptor and MMP-2/-9 pathway mediate the proangiogenic effect of nicotine in human retinal endothelial cells.Invest Ophthalmol Vis Sci. 2011 Jun 22;52(7):4428-38. doi: 10.1167/iovs.10-5461. Invest Ophthalmol Vis Sci. 2011. PMID: 20554619 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical